+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Tissue Papers - Global Strategic Business Report

  • PDF Icon

    Report

  • 370 Pages
  • November 2026
  • Region: Global
  • Market Glass, Inc.
  • ID: 6107001
The global market for Tissue Papers was valued at US$98.8 Billion in 2025 and is projected to reach US$129.3 Billion by 2032, growing at a CAGR of 3.9% from 2025 to 2032. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Tissue Papers Market - Key Trends & Drivers Summarized

Is the Humble Tissue Paper Now a Marker of Hygiene Evolution and Eco-Innovation?

Tissue papers, once considered basic hygiene products, have evolved into high-demand, fast-moving consumer goods that reflect both lifestyle trends and environmental awareness. This product category - encompassing facial tissues, toilet paper, paper towels, napkins, and specialty wipes - has witnessed steady global growth due to increasing urbanization, heightened hygiene awareness, and shifting consumer preferences toward convenience and disposability. The pandemic years further reinforced tissue paper’s role as an essential commodity, pushing manufacturers to optimize production capacities and diversify product portfolios.

What was traditionally a low-margin, volume-driven business has become more sophisticated with the emergence of premium tissue variants - ultra-soft, anti-bacterial, lotion-infused, and even scented papers - that cater to discerning consumers. Growing demand from commercial institutions such as hotels, hospitals, schools, and corporate offices has also boosted B2B consumption. Meanwhile, eco-conscious buyers are increasingly seeking sustainable alternatives such as recycled content, bamboo-based tissue, or products certified for responsible forestry. These evolving preferences are shaping not only product innovation but also packaging formats and distribution strategies in developed and emerging markets alike.

How Are Technology and Sustainability Driving Manufacturing Transformation?

The tissue manufacturing industry is undergoing a technological transformation, with automation, digitization, and sustainability shaping next-generation production. Advanced tissue machines with high-speed converting lines, real-time monitoring, and automatic reel handling have increased throughput while reducing labor dependency. Manufacturers are also using predictive maintenance systems and data analytics to enhance uptime and reduce waste, particularly important in large-scale operations producing thousands of tons annually.

Sustainability is at the core of many innovations. Efforts are focused on reducing water and energy use during pulping and drying - two of the most resource-intensive steps. Technologies such as Through-Air Drying (TAD) and NTT (New Tissue Technology) are enabling higher softness and absorbency at lower fiber input and energy costs. The shift toward chlorine-free bleaching, eco-friendly adhesives, biodegradable packaging, and plastic-free wrapping is gaining traction among producers targeting green certifications. These technological and environmental considerations are transforming tissue production from traditional pulp-heavy methods into circular and resource-efficient systems, critical in an era of climate accountability and consumer scrutiny.

Can Premiumization and E-Commerce Expand Market Reach and Consumer Loyalty?

The rise of premium and specialty tissues is redefining the tissue paper market's dynamics. Consumers are willing to pay more for comfort, aesthetics, and added functionality - whether it's hypoallergenic toilet paper, facial tissues with aloe, or antibacterial kitchen rolls. This trend has spurred segmentation and brand differentiation, especially in urban and high-income markets. Product lines are now categorized not just by ply count or packaging size, but also by skin sensitivity, scent, design, and environmental profile.

E-commerce and direct-to-consumer (DTC) models are accelerating this transformation. Online platforms are ideal for bulk purchases, subscription services, and promoting eco-friendly niche brands that may not be widely available in physical retail. Innovative packaging - flat-packed rolls, compressed towels, or refillable tissue containers - are designed for online logistics and consumer convenience. Brands are also investing in influencer marketing and lifestyle positioning, turning tissue products from mere utilities into symbols of personal care and social responsibility. These trends are expanding market boundaries, creating new loyalty drivers, and reshaping purchase behavior across geographies and age groups.

What Is Fueling the Expansion of the Global Tissue Papers Market?

The growth in the tissue papers market is driven by several factors rooted in technology, end-use diversification, and sustainable consumption patterns. First, the increasing demand for hygiene products in residential, commercial, and institutional settings is fueling consistent volume growth across tissue paper categories. Second, the adoption of advanced tissue machines and automation systems is enhancing operational efficiency, enabling high-speed, low-waste production of customized paper variants.

Third, growing environmental consciousness is driving demand for recycled, FSC-certified, and bamboo-based tissue products, encouraging innovation in pulp sourcing and eco-friendly processing. Fourth, the surge in e-commerce and digital retail platforms is expanding reach and brand visibility for both legacy and emerging tissue paper brands. Fifth, the rise in premiumization - driven by consumer desire for softness, skin sensitivity, and added features - is increasing product differentiation and margins. Lastly, government-led initiatives on sanitation, increasing disposable income, and population growth in developing economies are providing strong tailwinds for market expansion. These factors collectively ensure that tissue papers remain not only essential daily-use products but also dynamic contributors to sustainable, consumer-centered innovation in hygiene and personal care.

Report Scope

The report analyzes the Tissue Papers market, presented in terms of market value (US$). The analysis covers the key segments and geographic regions outlined below:
  • Segments: Product (Toilet Paper, Facial Tissue, Paper Towel, Other Tissue Paper Products); Distribution Channel (Supermarkets / Hypermarkets, Convenience Stores, Online Distribution Channel, Drug & Pharmacy Stores); Application (Commercial Application, Residential Application)
  • Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Toilet Paper segment, which is expected to reach US$58.1 Billion by 2032 with a CAGR of a 3.4%. The Facial Tissue segment is also set to grow at 3.5% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, valued at $26.9 Billion in 2025, and China, forecasted to grow at an impressive 6.7% CAGR to reach $26.1 Billion by 2032. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Tissue Papers Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Tissue Papers Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Tissue Papers Market expected to evolve by 2032?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2032?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2025 to 2032.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of players such as APP (Asia Pulp & Paper), Cascades Inc., Clearwater Paper Corporation, Essity AB, Georgia-Pacific LLC and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the companies featured in this Tissue Papers market report include:

  • APP (Asia Pulp & Paper)
  • Cascades Inc.
  • Clearwater Paper Corporation
  • Essity AB
  • Georgia-Pacific LLC
  • GP Cellulose
  • Hengan International Group
  • Irving Consumer Products
  • Kimberly-Clark Corporation
  • Lee & Man Paper Manufacturing
  • Metsä Tissue Corporation
  • Mondi Group
  • Nippon Paper Industries Co.
  • Oji Holdings Corporation
  • Procter & Gamble Co.
  • SCA (now part of Essity)
  • Sofidel Group
  • Sun Paper Group
  • UPM-Kymmene Corporation
  • Wausau Paper Corporation

What Sets This Report Apart From Others?

  • Grounded in Domain Expert Perspectives: Incorporates perspectives emerging from domain experts across industry, enterprise and academia, adding context beyond conventional published research.
  • Captures Early Market Signals: Tracks shifts emerging through expert conversations, company activity and market-relevant discussions before they are fully reflected in traditional secondary research.
  • Draws From a Broad, Validated Intelligence Base: Brings together insights from conference sessions, keynotes, panel discussions, blogs, corporate disclosures, annual reports, institutional publications and other validated sources.
  • Connects Signals With Strategic Market Direction: Synthesizes these perspectives to identify where the market is moving, what is driving that movement and which developments are likely to matter most for strategy.
  • Provides In-Depth Company Intelligence: Extends beyond market-level analysis to examine the companies participating in and shaping the competitive environment.
  • Market Share Is Examined Where It Matters: A single global market share figure rarely tells the full story. Competitive structures can vary significantly across geographies. Where analytically relevant, the report extends market share analysis into major regions with the level of detail tailored to the structure and dynamics of each market.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
  • World Market Trajectories
  • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
  • Tissue-based Genomic Profiling - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Rising Adoption of Precision Oncology Drives Demand for Tissue-Based Genomic Profiling
  • Expansion of Targeted Therapy Approvals Spurs Need for Biomarker-Driven Diagnostics
  • Increased Use of NGS Platforms in Hospital and Academic Labs Enhances Testing Capacity
  • Growing Emphasis on Tumor Heterogeneity Analysis Fuels Multiplexed Genomic Assay Adoption
  • Integration of Genomic Profiling With Clinical Decision Support Tools Improves Treatment Personalization
  • Wider Insurance Coverage for Companion Diagnostics Expands Accessibility in Oncology Care
  • Increased Inclusion of Genomic Testing in Clinical Trials Strengthens Institutional Demand
  • Technological Advancements in FFPE Sample Processing Improve Assay Accuracy
  • Rising Prevalence of Solid Tumors Supports Market Growth in Breast, Lung, and Colorectal Cancer Segments
  • Adoption of Pan-Cancer Genomic Panels Accelerates Standardization in Diagnostic Workflows
  • Growth in Oncology Centers and Molecular Pathology Labs Drives Test Volume Growth
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Tissue-based Genomic Profiling Market Analysis of Annual Sales in US$ Thousand for Years 2020 through 2032
  • Table 2: World Recent Past, Current & Future Analysis for Tissue-based Genomic Profiling by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 3: World Historic Review for Tissue-based Genomic Profiling by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 4: World 13-Year Perspective for Tissue-based Genomic Profiling by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2020, 2026 & 2032
  • Table 5: World Recent Past, Current & Future Analysis for Sequencing Techniques by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 6: World Historic Review for Sequencing Techniques by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 7: World 13-Year Perspective for Sequencing Techniques by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 8: World Recent Past, Current & Future Analysis for Immunohistochemistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 9: World Historic Review for Immunohistochemistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 10: World 13-Year Perspective for Immunohistochemistry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 11: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 12: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 13: World 13-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 14: World Recent Past, Current & Future Analysis for Diagnostic Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 15: World Historic Review for Diagnostic Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 16: World 13-Year Perspective for Diagnostic Laboratories End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 17: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 18: World Historic Review for Pharma & Biotech Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 19: World 13-Year Perspective for Pharma & Biotech Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 20: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 21: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 22: World 13-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 23: World Recent Past, Current & Future Analysis for Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 24: World Historic Review for Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 25: World 13-Year Perspective for Research Institutes End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 26: World Recent Past, Current & Future Analysis for Clinical Research Organizations End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 27: World Historic Review for Clinical Research Organizations End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 28: World 13-Year Perspective for Clinical Research Organizations End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 29: World Recent Past, Current & Future Analysis for Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 30: World Historic Review for Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 31: World 13-Year Perspective for Hospitals & Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 32: World Recent Past, Current & Future Analysis for Personalized Medicine Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 33: World Historic Review for Personalized Medicine Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 34: World 13-Year Perspective for Personalized Medicine Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 35: World Recent Past, Current & Future Analysis for Oncological Diagnostics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 36: World Historic Review for Oncological Diagnostics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 37: World 13-Year Perspective for Oncological Diagnostics Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 38: World Recent Past, Current & Future Analysis for Research Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 39: World Historic Review for Research Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 40: World 13-Year Perspective for Research Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
III. MARKET ANALYSIS
UNITED STATES
  • Tissue-based Genomic Profiling Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2026 (E)
CANADA
JAPAN
  • Tissue-based Genomic Profiling Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2026 (E)
CHINA
  • Tissue-based Genomic Profiling Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2026 (E)
EUROPE
  • Tissue-based Genomic Profiling Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2026 (E)
FRANCE
  • Tissue-based Genomic Profiling Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2026 (E)
GERMANY
  • Tissue-based Genomic Profiling Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2026 (E)
ITALY
UNITED KINGDOM
  • Tissue-based Genomic Profiling Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2026 (E)
SPAINRUSSIAREST OF EUROPE
ASIA-PACIFIC
  • Tissue-based Genomic Profiling Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2026 (E)
AUSTRALIA
  • Tissue-based Genomic Profiling Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2026 (E)
INDIA
  • Tissue-based Genomic Profiling Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2026 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Tissue-based Genomic Profiling Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2026 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Tissue-based Genomic Profiling Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2026 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Tissue-based Genomic Profiling Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2026 (E)
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • APP (Asia Pulp & Paper)
  • Cascades Inc.
  • Clearwater Paper Corporation
  • Essity AB
  • Georgia-Pacific LLC
  • GP Cellulose
  • Hengan International Group
  • Irving Consumer Products
  • Kimberly-Clark Corporation
  • Lee & Man Paper Manufacturing
  • Metsä Tissue Corporation
  • Mondi Group
  • Nippon Paper Industries Co.
  • Oji Holdings Corporation
  • Procter & Gamble Co.
  • SCA (now part of Essity)
  • Sofidel Group
  • Sun Paper Group
  • UPM-Kymmene Corporation
  • Wausau Paper Corporation

Table Information